Literature DB >> 27179418

Reversible oxidation controls the activity and oligomeric state of the mammalian phosphoglycolate phosphatase AUM.

Annegrit Seifried1, Alexandre Bergeron2, Benoit Boivin3, Antje Gohla4.   

Abstract

Redox-dependent switches of enzyme activity are emerging as important fine-tuning mechanisms in cell signaling. For example, protein tyrosine phosphatases employ a conserved cysteine residue for catalysis, which also renders them highly susceptible to reversible inactivation by oxidation. In contrast, haloacid dehalogenase (HAD)-type phosphatases perform catalysis via a phosphoaspartyltransferase reaction. The potential regulation of HAD phosphatases by reversible oxidation has not yet been explored. Here, we investigate the redox-sensitivity of the HAD-type phosphoglycolate phosphatase PGP, also known as AUM or glycerol-3-phosphate phosphatase. We show that recombinant, purified murine PGP is inhibited by oxidation and re-activated by reduction. We identify three reactive cysteine residues in the catalytic core domain of PGP (Cys35, Cys104 and Cys243) that mediate the reversible inhibition of PGP activity and the associated, redox-dependent conformational changes. Structural analysis suggests that Cys35 oxidation weakens van-der-Waals interactions with Thr67, a conserved catalytic residue required for substrate coordination. Cys104 and Cys243 form a redox-dependent disulfide bridge between the PGP catalytic core and cap domains, which may impair the open/close-dynamics of the catalytic cycle. In addition, we demonstrate that Cys297 in the PGP cap domain is essential for redox-dependent PGP oligomerization, and that PGP oxidation/oligomerization occurs in response to stimulation of cells with EGF. Finally, employing a modified cysteinyl-labeling assay, we show that cysteines of cellular PGP are transiently oxidized to sulfenic acids. Taken together, our findings establish that PGP, an aspartate-dependent HAD phosphatase, is transiently inactivated by reversible oxidation in cells.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUM; Cysteinyl-labeling assay; EGF; Glycerol-3-phosphate phosphatase; Haloacid dehalogenase-type phosphatase; Phosphoglycolate phosphatase; Reactive oxygen species; Reversible cysteine oxidation

Mesh:

Substances:

Year:  2016        PMID: 27179418     DOI: 10.1016/j.freeradbiomed.2016.05.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  5 in total

1.  The Photorespiratory Metabolite 2-Phosphoglycolate Regulates Photosynthesis and Starch Accumulation in Arabidopsis.

Authors:  Franziska Flügel; Stefan Timm; Stéphanie Arrivault; Alexandra Florian; Mark Stitt; Alisdair R Fernie; Hermann Bauwe
Journal:  Plant Cell       Date:  2017-09-25       Impact factor: 11.277

2.  An essential developmental function for murine phosphoglycolate phosphatase in safeguarding cell proliferation.

Authors:  Gabriela Segerer; Kerstin Hadamek; Matthias Zundler; Agnes Fekete; Annegrit Seifried; Martin J Mueller; Frank Koentgen; Manfred Gessler; Elisabeth Jeanclos; Antje Gohla
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

3.  Phosphoglycolate has profound metabolic effects but most likely no role in a metabolic DNA response in cancer cell lines.

Authors:  Isabelle Gerin; Marina Bury; Francesca Baldin; Julie Graff; Emile Van Schaftingen; Guido T Bommer
Journal:  Biochem J       Date:  2019-02-19       Impact factor: 3.857

4.  Insights into the function of NADPH thioredoxin reductase C (NTRC) based on identification of NTRC-interacting proteins in vivo.

Authors:  Maricruz González; Víctor Delgado-Requerey; Julia Ferrández; Antonio Serna; Francisco Javier Cejudo
Journal:  J Exp Bot       Date:  2019-10-24       Impact factor: 6.992

Review 5.  New Mammalian Glycerol-3-Phosphate Phosphatase: Role in β-Cell, Liver and Adipocyte Metabolism.

Authors:  Elite Possik; Anfal Al-Mass; Marie-Line Peyot; Rasheed Ahmad; Fahd Al-Mulla; S R Murthy Madiraju; Marc Prentki
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-13       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.